Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...

New CLASSIC technique uses AI and massive DNA libraries to predict genetic circuit performance faster and more accurately.

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

Logistical management of the cold chain has constantly evolved. How are today’s companies providing a “future ready” ...

The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

Platform Technologies – Capsids Solid continues to broaden access to its proprietary next-generation capsid, AAV-SLB101, designed with the goal of enhancing skeletal muscle and cardiac tropism with ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...

A newly identified enzyme appears to control tau production, brain inflammation, and aging. Researchers at the University of ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

Researchers used Google DeepMind’s AlphaFold2 and ProteinMPNN to speed development of antibody-based probes that can be used to see key functions and chemical changes inside living cells as they ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...